CIK 0001501697
- Non-accelerated filer
- Smaller reporting company
X4 Pharmaceuticals, Inc
Sign in to watch- Ticker
- XFOR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 273181608
- Phone
- +1 857-529-8300
- Business address
- 61 NORTH BEACON STREET, 4TH FLOOR, BOSTON, MA, 02134
- Former names
- Arsanis, Inc.
- Open-market buys, last 90 days
- $11,884
- in 1 filing
- Open-market sales, last 90 days
- $33,658
- in 1 filing
Net −$21,775. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-03-13 | Ragan Paula President and CEO | Grant or award | +181,366 | 181,366 | ||
| 2019-03-13 | Ragan Paula President and CEO | Grant or award · Stock Option (right to buy) | +100,729 | 100,729 | ||
| 2019-03-13 | Ragan Paula President and CEO | Grant or award · Stock Option (right to buy) | +65,430 | 65,430 | ||
| 2019-03-13 | Ragan Paula President and CEO | Grant or award · Stock Option (right to buy) | +80,160 | 80,160 | ||
| 2018-11-27 | GRAY MICHAEL President, CEO and CFO | Grant or award | +250,000 | 250,000 | ||
| 2018-06-05 | MCGUIRE TERRANCE Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2018-06-05 | SCHULMAN AMY W Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2018-06-05 | Ross Michael Jay Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2018-06-05 | Nessi Claudio Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2018-06-05 | MCGIRR DAVID W J Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2018-06-05 | GORDON CARL L Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2018-06-05 | Gerngross Tillman U. Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2018-06-05 | Clark William D Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2018-03-07 | GRAY MICHAEL COO and CFO | Grant or award · Stock option (right to buy) | +110,000 | 110,000 | ||
| 2018-03-07 | Mantus David Chief Development Officer | Grant or award · Stock option (right to buy) | +50,000 | 50,000 | ||
| 2018-03-07 | Nagy Eszter Chief Scientific Officer | Grant or award · Stock option (right to buy) | +45,000 | 45,000 | ||
| 2018-03-07 | Russo Rene President and CEO | Grant or award · Stock option (right to buy) | +160,000 | 160,000 | ||
| 2018-03-07 | STEVENS ANTHONY CHRIS Chief Medical Officer | Grant or award · Stock option (right to buy) | +50,000 | 50,000 | ||
| 2017-11-20 | EMBL Technology Fund II GmbH & Co. KG 10% owner | Conversion | +103,278 | 103,278 | ||
| 2017-11-20 | EMBL Technology Fund II GmbH & Co. KG 10% owner | Conversion | +247,176 | 350,454 |
Page 14 of 25 · 490 trades